Fluvoxamine for the treatment of COVID-19 - Author's reply

Lancet Glob Health. 2022 Mar;10(3):e333. doi: 10.1016/S2214-109X(21)00588-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19* / drug therapy
  • Fluvoxamine / therapeutic use
  • Humans
  • SARS-CoV-2

Substances

  • Fluvoxamine

Supplementary concepts

  • COVID-19 drug treatment